It is one of the questions we get asked most often at the moment, usually phrased carefully, because the person asking already suspects the answer. Retatrutide is being sold all over the internet. So is it legal to buy?
No. And it is worth understanding why, because the reason tells you a great deal about what is actually in those vials.
Nothing has been approved yet
Retatrutide is an experimental obesity drug from Eli Lilly. It is genuinely promising. Trials have reported weight loss on a scale previously associated with surgery, which is why it has generated so much noise.
What it has not done is finish the process. No regulator anywhere in the world has approved retatrutide, and Lilly has indicated it expects to apply to the FDA next year. Until that happens there is no approved manufacturer, no established dose, and no lawful route for a clinic or a pharmacy to supply it to a patient.
So when a website offers it to you today, that website is operating outside the system entirely.
The sellers are now being sued
In August 2026 Lilly filed six lawsuits against businesses it accuses of selling untested retatrutide as a weight-loss product. The company has also referred more than 200 individuals and businesses to regulators, and flagged over 14,000 websites, adverts and listings across more than 100 countries.
A common thread in those cases is the phrase “research use only” printed on products plainly intended for people to inject. That wording is not a safety standard or a legal shield. It exists to move liability from the seller to you.
What that means for what is in the vial
An unapproved product has no independent oversight of any kind. Lilly has cautioned that black-market versions may be counterfeit, contaminated or incorrectly dosed, and there is no test a patient can run at home to find out which one arrived.
Consider what is missing. No verified concentration, so the dose written on the label may bear no relation to the contents. No verified purity. No guarantee of sterility in something you are injecting. No pharmacist checking it against your other medications, and no physician monitoring how you respond.
If something goes wrong, there is also nobody accountable. An approved medicine has a manufacturer, a licensed pharmacy, a prescriber and a formal adverse-event reporting system standing behind it. An overseas peptide seller has a website that can disappear overnight.
This is not a new pattern, and we have written about it before in our guide to black and gray market peptides. Retatrutide is simply the current chapter.
Where our clinic stands
We do not offer retatrutide, and we will not until it is approved and can be supplied lawfully through licensed pharmacies. At that point we will be glad to, because the clinical data looks strong.
Our position is not about this particular drug. We only prescribe medications that are approved, sourced properly, and dispensed after an actual consultation with a physician who has reviewed your history. You can read more about how we approach safety and FDA approval.
If you find a clinic willing to sell you retatrutide right now, that is information about the clinic. The rules being ignored are the ones protecting you.
What is available legally today
Semaglutide and tirzepatide are both approved, both supported by substantial evidence, and both available now. For nearly everyone asking us about retatrutide, one of them is the right treatment, and it can be started properly rather than gambled on.
You can read about the GLP-1 treatments we offer, or get started with a consultation whenever you are ready.
Source: BioPharma Dive, “Lilly sues sellers of black-market retatrutide”.